Health & Safety Industry Today

Chronic Disease Management Market to Cross USD 15.58 Billion by 2032 Propeled by Digital Transformation in Healthcare – SNS Insider

SNS Insider projects the U.S. Chronic Disease Management Market to grow from USD 1.41 Billion in 2023 to USD 4.43 Billion by 2032, at a CAGR of 13.38%. Global adoption of AI-powered chronic care platforms and telehealth monitoring reshapes long-term disease management.
Published 07 November 2025

SNS Insider reported that global Chronic Disease Management Market was valued at USD 4.83 billion in 2023 and is projected to reach USD 15.58 billion by 2032, expanding at a CAGR of 13.74% from 2024 to 2032.

The U.S. led the market with a valuation of USD 1.41 billion in 2023, expected to achieve USD 4.43 billion by 2032, supported by rapid adoption of digital health technologies, increased prevalence of chronic illnesses, and policy initiatives promoting value-based care models.

The global rise in chronic conditions such as cardiovascular diseases, diabetes, respiratory illnesses, and obesity continues to drive demand for advanced care management platforms. The integration of artificial intelligence, predictive analytics, and telehealth monitoring is transforming long-term care delivery, improving patient engagement, and reducing overall healthcare costs.

Get free Sample Report of Chronic Disease Management Market: https://www.snsinsider.com/sample-request/6623

Chronic Disease Management Market Overview

Chronic Disease Management (CDM) solutions are designed to provide continuous monitoring, patient education, and coordinated care for individuals living with long-term conditions. The global healthcare landscape is shifting from reactive to preventive and proactive care models, with digital transformation playing a central role.

These platforms allow healthcare providers to remotely track patient progress, ensure medication adherence, and deliver timely interventions, helping to lower hospital admissions and enhance treatment outcomes.

The ongoing expansion of connected health systems, government-funded telemedicine programs, and increased patient awareness are expected to sustain strong growth in the Chronic Disease Management Market throughout the forecast period.

Major Players in the Chronic Disease Management Market Include:

  • Philips Healthcare (HealthSuite Digital Platform, eCareCoordinator)
  • IBM Corporation (Watson Health, Micromedex Solutions)
  • Siemens Healthineers (teamplay, AI-Rad Companion)
  • GE Healthcare (Mural Virtual Care, Centricity Practice Solution)
  • Allscripts Healthcare Solutions (FollowMyHealth, CareInMotion)
  • Cerner Corporation (HealtheIntent, PowerChart)
  • Epic Systems Corporation (MyChart, Healthy Planet)
  • McKesson Corporation (RelayHealth, InterQual)
  • Oracle Corporation (Oracle Health Management System, Oracle Care Management Cloud)
  • Teladoc Health, Inc. (Chronic Care Complete, Livongo for Diabetes)
  • Medtronic plc (CareLink System, Guardian Connect)
  • Omada Health (Omada for Diabetes, Omada for Hypertension)
  • Health Catalyst (Care Management Suite)
  • Cognizant Technology Solutions (TriZetto CareAdvance)
  • WellDoc, Inc. (BlueStar for Diabetes)
  • eClinicalWorks (Healow, Chronic Care Management Module)
  • CareCloud, Inc. (CareCloud Central)
  • Lumeon Inc. (Care Pathway Manager)
  • NextGen Healthcare (NextGen Population Health)
  • Virgin Pulse (VP Transform for Diabetes, VP Navigate)

Chronic Disease Management Market Segment Insights

By Disease Type

The Cardiovascular Diseases segment dominated the market with a 43.11% share in 2023, largely due to the global prevalence of heart-related conditions such as hypertension, coronary artery disease, and heart failure. The World Health Organization estimates that more than 17 million deaths occur annually due to cardiovascular complications.

Chronic disease management platforms for cardiovascular care enable continuous tracking of vital biomarkers such as blood pressure, glucose levels, and cholesterol, allowing for early detection and timely interventions. Growing integration of wearable sensors, AI-enabled risk assessment tools, and remote cardiac monitoring technologies further supports this segment’s leadership.

By Service Type

The Consulting Services segment accounted for a 42.31% share in 2023, driven by the growing need for expert guidance in implementing and optimizing chronic care solutions. As healthcare systems digitize and adopt new care models, consulting services are essential for managing regulatory compliance, interoperability, and workflow integration.

Healthcare organizations rely on consultants to tailor solutions that meet the unique requirements of chronic care programs and ensure smooth transition from traditional systems to advanced data-driven platforms.

By Delivery Mode

The Web-based delivery mode led the market with a 38.20% share in 2023, thanks to its accessibility, cost efficiency, and easy integration into existing IT infrastructures. Web-based platforms facilitate real-time data exchange between patients and providers, supporting virtual visits and long-term disease monitoring.

The Cloud-based segment is projected to witness the fastest growth through 2032, benefiting from scalability, data security, and interoperability. Cloud solutions enable integration of AI, machine learning, and predictive analytics, essential for population health management and personalized treatment.

By End User

The Providers segment dominated the market with a 78.25% share in 2023, underscoring the central role of hospitals, clinics, and physicians in chronic care delivery. Providers are increasingly adopting digital tools to improve patient adherence, streamline care coordination, and reduce hospital readmissions.

Supportive reimbursement models and government incentives for chronic care programs continue to reinforce this segment’s strong growth trajectory.

Chronic Disease Management Market Regional Insights

North America led the market with a 41.62% share in 2023, supported by advanced healthcare infrastructure, high digital adoption, and favorable reimbursement for chronic care services. The region’s leadership is strengthened by government initiatives in telehealth expansion and the presence of key players such as Philips, IBM, and Cerner.

Asia Pacific is expected to grow at the fastest CAGR of 14.51% from 2024 to 2032, driven by a rapidly aging population, increasing chronic disease burden, and accelerated digitalization of healthcare systems. Countries like China, India, and Japan are heavily investing in telemedicine and mHealth platforms. Government-backed digital health initiatives and public-private collaborations are enhancing accessibility and affordability across the region.

Buy the Chronic Disease Management Market Report Now: https://www.snsinsider.com/checkout/6623

Recent Developments in the Chronic Disease Management Market

  • In April 2025, Philips Healthcare launched an AI-powered cardiac monitoring suite to support real-time decision-making in chronic heart disease management.
  • IBM Watson Health introduced advanced predictive analytics for diabetes and hypertension management to reduce hospitalizations.
  • Teladoc Health expanded its virtual care offerings to include integrated chronic disease support under its Livongo brand.
  • Medtronic unveiled enhanced remote monitoring features in its Guardian Connect platform to help clinicians optimize diabetes management.
  • Cerner Corporation announced a partnership with Omada Health to create a unified digital ecosystem for chronic condition monitoring.

Statistical Insights

  • Cardiovascular disease remains the leading cause of global mortality, responsible for more than 30% of all deaths worldwide.
  • Over 60% of healthcare organizations in the U.S. have implemented or plan to implement chronic disease management software by 2026.
  • Cloud-based adoption in healthcare is expected to surpass 50% penetration in chronic care management within the next five years.
  • Chronic diseases collectively account for over 75% of total healthcare expenditures in developed markets.

Other Trending Reports

Molecular Diagnostics Market

Mental Health Apps Market

Robotic Surgical Procedures Market

Hemoglobinopathies Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Rohan Jadhav - Principal Consultant

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Email: info@snsinsider.com

Other Industry News

Ready to start publishing

Sign Up today!